Back to results
US 2006/0188493 A1Published application
Use of an active substance that binds to cd28 for producing a pharmaceutical composition
AssigneeTegenero AG
InventorHuenig Thomas
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a CD28-specific superagonistic monoclonal antibody (mAb) or of a mimic compound of the same for producing a pharmaceutical composition for the induction and/or reproduction of regulatory T-cells.
Claims8
The use of a CD28-specific superagonistic monoclonal antibody (mAb) or of a mimic compound of the same for producing a pharmaceutical composition for the induction and/or reproduction of regulatory T-cells in vitro and/or in vivo.
Dependencies are inferred from the claim text.